Procter & Gamble
PG
$144.49
+0.37%
Procter & Gamble (PG) is a global consumer goods giant, manufacturing and marketing a diversified portfolio of household and personal care products, including iconic brands like Tide, Charmin, Pantene, and Pampers, with annual sales approaching $85 billion. As one of the world's largest consumer product manufacturers, PG holds a dominant market position across multiple categories, with over 20 brands each generating more than $1 billion in annual sales, and derives just over half of its revenue from international markets. The current investor narrative centers on PG's defensive appeal amid market volatility, its consistent dividend growth as a 'Dividend King,' and its ability to maintain modest organic growth through premiumization and innovation, while navigating input cost inflation and currency headwinds. Recent attention has been drawn to the stock's relative underperformance versus the broader market, with a 1-year price decline of 3.97% compared to the S&P 500's 18.19% gain, prompting debates about whether this represents a value opportunity or a reflection of structural challenges in the consumer staples sector.…
PG
Procter & Gamble
$144.49
Related headlines
Investment Opinion: Should I buy PG Today?
Based on the data, PG is rated a Hold. The stock offers a defensive profile with a 2.88% dividend yield and a forward P/E of 19.50x, which is a 13.3% discount to the industry average. However, the modest upside to the average analyst target of $161.00 (11.4%) and the stock's underperformance relative to the market limit its appeal. The thesis is that PG is a quality company but not a compelling buy at current levels, given its low growth and lack of momentum.
Sign up to view all
PG 12-Month Price Forecast
The AI assessment is neutral, as PG offers a defensive profile with a reasonable valuation, but its growth is modest and the stock has underperformed. The forward P/E discount to peers provides a margin of safety, but the PEG ratio of 18.11x suggests limited upside. The stance would be upgraded to bullish if revenue growth accelerates above 5% and the stock breaks above its 50-day moving average, or downgraded to bearish if the company cuts its dividend growth or revenue growth falls below 2%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Procter & Gamble's 12-month outlook, with a consensus price target around $160.70 and implied upside of +11.2% versus the current price.
Average Target
$160.70
0 analysts
Implied Upside
+11.2%
vs. current price
Analyst Count
—
covering this stock
Price Range
$145 - $186
Analyst target range
PG is covered by 23 analysts, with a consensus recommendation of 'Buy' and a mean recommendation score of 2.12 (where 1 is Strong Buy and 5 is Sell). The average price target is $161.00, implying an upside of 11.4% from the current price of $144.49. The distribution of ratings is not explicitly provided, but the mean score of 2.12 suggests a mix of Buy and Overweight ratings, with some Hold ratings, leaning bullish. Recent institutional actions show a consistent pattern of reaffirmations rather than upgrades or downgrades, with firms like B of A Securities, Wells Fargo, and UBS maintaining Buy/Overweight ratings, while Evercore ISI and Barclays hold In Line/Equal Weight stances. The target price range spans from a low of $145.00 to a high of $186.00, with the low target only slightly above the current price, indicating that some analysts see limited upside, while the high target implies a 28.7% upside, reflecting expectations of a strong recovery. The wide spread between low and high targets (a 28.3% difference from low to high) signals moderate uncertainty about PG's future performance, likely due to concerns about consumer spending, input costs, and the company's ability to drive growth in a mature market. The consensus target of $161.00 suggests that analysts believe the stock is undervalued at current levels, but the modest upside indicates a cautious optimism rather than a strong conviction in a major re-rating.
Bulls vs Bears: PG Investment Factors
PG presents a classic defensive value profile: strong profitability, a reliable dividend, and a valuation below its historical average. However, the stock has significantly underperformed the market, and its growth is modest, with a PEG ratio of 18.11x indicating that the market is not paying for growth. The bull case rests on the stock's attractive forward P/E of 19.50x and the potential for a re-rating if growth accelerates, while the bear case highlights the lack of momentum and the risk of continued underperformance. The most important tension is whether PG's modest organic growth and premiumization strategy can justify a re-rating, or if the stock remains a value trap in a sector facing structural headwinds. Currently, the evidence slightly favors the bull case due to the valuation discount and analyst consensus, but the risk of continued underperformance is real.
Bullish
- Strong Q3 Revenue Growth: Q3 FY2026 revenue grew 7.38% YoY to $21.235 billion, a notable acceleration from the 3.1% growth in Q1 FY2026. This suggests pricing power and resilient demand despite a mature market.
- Attractive Valuation vs. History: Trailing P/E of 21.72x is near the lower end of its 5-year range (19.2x-31.3x), and forward P/E of 19.50x is a 13.3% discount to the industry forward average of 22.5x. This implies the market is pricing in conservative growth expectations.
- Consistent Dividend Growth: PG is a Dividend King with a payout ratio of 63.8% and a dividend yield of 2.88%. Its track record of consistent dividend increases provides a reliable income stream and supports long-term total return.
- High Profitability and ROE: Return on equity is 29.5%, with a net margin of 18.4% and operating margin of 22.7%. These metrics demonstrate strong operational efficiency and brand pricing power.
Bearish
- Underperformance vs. Market: PG's 1-year price change is -3.97% versus the S&P 500's +18.19%, a relative underperformance of 22.2 percentage points. This suggests persistent selling pressure and a lack of investor enthusiasm.
- High Valuation on PEG Basis: The PEG ratio is 18.11x, indicating that the stock is expensive relative to its expected earnings growth. This implies the market is paying a premium for limited growth prospects.
- Sequential Revenue Decline: Revenue declined from $22.386 billion in Q1 FY2026 to $21.235 billion in Q3 FY2026, a sequential drop of 5.1%. This raises concerns about demand sustainability and potential market share loss.
- Low Beta but High Relative Risk: Beta of 0.38 indicates low market correlation, but the stock's 52-week low of $137.62 is only 4.7% below the current price. This leaves limited downside cushion if negative catalysts emerge.
PG Technical Analysis
PG's prevailing price trend over the past year is a mild downtrend, with the stock declining 3.97% over the last 12 months, a stark contrast to the S&P 500's 18.19% gain. Currently trading at $144.49, the stock sits at 86.4% of its 52-week range (between the low of $137.62 and high of $167.25), indicating it is closer to the lower end of its yearly range. This positioning suggests the stock is in a corrective phase, potentially offering a value entry point, but also reflecting persistent selling pressure and a lack of momentum relative to the broader market. The 52-week low of $137.62 provides a critical support level, while the high of $167.25 represents significant resistance that the stock has failed to reclaim since February 2026.
Beta
0.38
0.38x market volatility
Max Drawdown
-16.1%
Largest decline past year
52-Week Range
$138-$167
Price range past year
Annual Return
-4.0%
Cumulative gain past year
| Period | PG Return | S&P 500 |
|---|---|---|
| 1m | -2.0% | +0.3% |
| 3m | -1.9% | +4.0% |
| 6m | -4.8% | +8.3% |
| 1y | -4.0% | +20.2% |
| ytd | +1.9% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PG Fundamental Analysis
PG's revenue trajectory shows a mixed picture: the most recent quarter (Q3 FY2026, ended March 31, 2026) reported revenue of $21.235 billion, up 7.38% year-over-year, but this growth is inconsistent when viewed across recent quarters. The prior quarter (Q2 FY2026) saw revenue of $22.208 billion, while Q1 FY2026 was $22.386 billion, indicating a sequential decline in the latest quarter. Over the trailing twelve months, revenue growth has been modest, with the company's annual sales near $85 billion, but the 7.38% YoY growth in Q3 suggests a temporary acceleration, possibly driven by pricing actions or favorable mix. However, the multi-quarter trend shows deceleration from the 3.1% growth in Q1 FY2026 (calculated from $21.737 billion in Q1 FY2025) to the current quarter's 7.38%, which is a positive sign but may not be sustainable. Segment-wise, Fabric Care and Home Care is the largest segment at $7.403 billion, followed by Baby, Feminine and Family Care at $5.058 billion, Beauty at $3.866 billion, Health Care at $3.073 billion, and Grooming at $1.608 billion, with all segments contributing to growth, though the smaller segments like Grooming may be lagging.
Quarterly Revenue
$21.2B
2026-03
Revenue YoY Growth
+7.4%
YoY Comparison
Gross Margin
49.5%
Latest Quarter
Free Cash Flow
$15.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PG Overvalued?
For valuation, I selected the P/E ratio as the primary metric because PG is highly profitable, with a trailing twelve-month net income of $16.67 billion (sum of last four quarters: $3.968B + $4.331B + $4.75B + $3.616B). The trailing P/E is 21.72x, while the forward P/E is 19.50x, based on estimated EPS of $6.78 for the next fiscal year. The gap between trailing and forward P/E (a 10.2% discount) implies the market expects earnings growth of approximately 11.4% (from EPS of $6.09 trailing to $6.78 forward), which is optimistic given PG's historical growth rates. Compared to the industry average P/E of 22.5x (based on the consumer staples sector), PG's trailing P/E of 21.72x is at a slight 3.5% discount, suggesting the stock is fairly valued relative to peers. However, PG's forward P/E of 19.50x is at a 13.3% discount to the industry forward average of 22.5x, indicating the market is pricing in lower growth expectations for PG than the sector. Historically, PG's P/E has ranged from 19.2x to 31.3x over the past five years, with the current trailing P/E of 21.72x sitting near the lower end of that range, suggesting the stock is trading at a valuation that is below its historical average, potentially offering a value opportunity if the company can sustain its growth.
PE
21.7x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 19x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
17.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks include PG's high payout ratio of 63.8%, which limits financial flexibility and could pressure the dividend if earnings decline. The company's debt-to-equity ratio of 0.63 is manageable, but its current ratio of 0.68 indicates potential liquidity concerns, though this is typical for the industry. Revenue concentration is diversified across segments, but the sequential decline in revenue from Q1 to Q3 FY2026 (from $22.386B to $21.235B) suggests potential demand softness. Additionally, the PEG ratio of 18.11x highlights that the stock is priced for very low growth, making it vulnerable to any earnings disappointment.
FAQ
The key risks of holding PG include: 1) Financial risk: high payout ratio of 63.8% limits financial flexibility, and a current ratio of 0.68 indicates potential liquidity concerns. 2) Competitive risk: pressure from private labels and smaller brands could erode market share. 3) Macro risk: input cost inflation and currency headwinds could compress margins. 4) Company-specific risk: if revenue growth decelerates below 2%, the stock could lose its defensive appeal. The most severe risk is a dividend cut, which would likely cause a significant sell-off.
The 12-month forecast for PG is a base case of $150-165, with a 50% probability, driven by modest growth and stable margins. The bull case targets $165-186 (25% probability) if growth accelerates and the stock re-rates, while the bear case targets $130-145 (25% probability) if growth disappoints. The most likely scenario is the base case, with the stock reaching the analyst average target of $161.00, implying 11.4% upside from the current price of $144.49.
PG is fairly valued relative to its peers, with a trailing P/E of 21.72x versus the industry average of 22.5x, a slight discount. Its forward P/E of 19.50x is a 13.3% discount to the industry forward average, suggesting the market is pricing in lower growth expectations. Historically, the stock's P/E has ranged from 19.2x to 31.3x over the past five years, and the current level is near the lower end, indicating it is undervalued relative to its own history. However, the PEG ratio of 18.11x suggests that the stock is expensive relative to its growth prospects, so the valuation is not a clear bargain.
PG is a good stock to buy for income-focused investors seeking a defensive holding with a 2.88% dividend yield and a long history of dividend increases. The stock is trading at a forward P/E of 19.50x, a 13.3% discount to the industry average, and analysts see 11.4% upside to the average target of $161. However, the stock has underperformed the market, and its growth is modest, so it may not be suitable for growth-oriented investors. A good entry point would be near the 52-week low of $137.62, which offers a better margin of safety.
PG is suitable for long-term investment, given its defensive nature, low beta of 0.38, and consistent dividend growth. The stock is not ideal for short-term trading due to its low volatility and lack of momentum, as evidenced by its 1-year underperformance. A minimum holding period of 3-5 years is recommended to benefit from dividend compounding and potential valuation re-rating. For income investors, PG can be a core holding, but for growth investors, it may not provide sufficient capital appreciation.